Clinical Tool for Cystic Fibrosis Waitlist Mortality

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: The Cleveland Clinic

No Placebo Group

Trial Summary

What is the purpose of this trial?

Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis

Research Team

Eligibility Criteria

This trial is for individuals with Cystic Fibrosis who are on the waitlist for a lung transplant and have bought a home spirometer. It's not suitable for those without Cystic Fibrosis, or people who can't read or use a computer/smartphone to access the required mobile app.

Inclusion Criteria

I am on the waiting list for a lung transplant.

You have bought a home spirometer.

I have been diagnosed with Cystic Fibrosis.

Exclusion Criteria

Unable to read

Unable to use computer or smartphone device to access mobile application

My diagnosis is not Cystic Fibrosis.

Treatment Details

Interventions

Mobile Spirometry and Survey (Behavioural Intervention)

Trial OverviewThe study is testing a clinical tool that includes mobile spirometry (a way to measure lung function) and surveys. The goal is to see if this tool can help reduce the number of patients with Cystic Fibrosis who die while waiting for a lung transplant.

Participant Groups

1Treatment groups

Experimental Treatment

Group I: Clinical Tool (Mobile Spirometry and Survey)Experimental Treatment1 Intervention

All subjects enrolled will be placed into the clinical tool arm. The clinical tool is comprised of a mobile application based assessment of home spirometry and a survey measuring patient reported outcomes.